OPCM
Osborne Partners Capital Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-25,541
| Closed | -$940K | – | 205 |
|
|
2020
Q4 | $940K | Buy |
+25,541
| New | +$940K | 0.11% | 119 |
|
|
2019
Q1 | – | Sell |
-25,671
| Closed | -$981K | – | 170 |
|
|
2018
Q4 | $981K | Hold |
25,671
| – | – | 0.15% | 110 |
|
|
2018
Q3 | $1.03M | Sell |
25,671
-262
| -1% | -$10.5K | 0.13% | 110 |
|
|
2018
Q2 | $1.05M | Buy |
25,933
+262
| +1% | +$10.6K | 0.14% | 107 |
|
|
2018
Q1 | $1M | Sell |
25,671
-70
| -0.3% | -$2.74K | 0.14% | 109 |
|
|
2017
Q4 | $913K | Buy |
25,741
+70
| +0.3% | +$2.48K | 0.12% | 115 |
|
|
2017
Q3 | $1.04M | Hold |
25,671
| – | – | 0.14% | 116 |
|
|
2017
Q2 | $1.11M | Hold |
25,671
| – | – | 0.16% | 106 |
|
|
2017
Q1 | $1.08M | Sell |
25,671
-1,357
| -5% | -$57.2K | 0.15% | 109 |
|
|
2016
Q4 | $1.04M | Sell |
27,028
-93
| -0.3% | -$3.58K | 0.15% | 110 |
|
|
2016
Q3 | $1.17M | Sell |
27,121
-400
| -1% | -$17.3K | 0.18% | 103 |
|
|
2016
Q2 | $1.19M | Hold |
27,521
| – | – | 0.18% | 105 |
|
|
2016
Q1 | $1.12M | Hold |
27,521
| – | – | 0.16% | 107 |
|
|
2015
Q4 | $1.11M | Buy |
27,521
+400
| +1% | +$16.1K | 0.16% | 108 |
|
|
2015
Q3 | $1.04M | Sell |
27,121
-26,650
| -50% | -$1.02M | 0.15% | 110 |
|
|
2015
Q2 | $2.24M | Sell |
53,771
-392
| -0.7% | -$16.3K | 0.3% | 83 |
|
|
2015
Q1 | $2.5M | Sell |
54,163
-136
| -0.3% | -$6.28K | 0.33% | 79 |
|
|
2014
Q4 | $2.32M | Sell |
54,299
-287
| -0.5% | -$12.3K | 0.28% | 82 |
|
|
2014
Q3 | $2.51M | Buy |
54,586
+253
| +0.5% | +$11.6K | 0.32% | 74 |
|
|
2014
Q2 | $2.91M | Sell |
54,333
-434
| -0.8% | -$23.2K | 0.37% | 71 |
|
|
2014
Q1 | $2.93M | Buy |
54,767
+484
| +0.9% | +$25.9K | 0.38% | 68 |
|
|
2013
Q4 | $2.9M | Sell |
54,283
-597
| -1% | -$31.9K | 0.38% | 68 |
|
|
2013
Q3 | $2.75M | Hold |
54,880
| – | – | 0.38% | 67 |
|
|
2013
Q2 | $2.74M | Buy |
+54,880
| New | +$2.74M | 0.39% | 67 |
|